The Vienna Prograf and Endothelial Progenitor Cell Study
|ClinicalTrials.gov Identifier: NCT00182559|
Recruitment Status : Completed
First Posted : September 16, 2005
Last Update Posted : February 5, 2014
Medical University of Vienna
Information provided by (Responsible Party):
Gere Sunder-Plassmann, Medical University of Vienna
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Completed|
|Actual Primary Completion Date :||May 2009|
|Actual Study Completion Date :||May 2009|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Plischke M, Riegersperger M, Dunkler D, Heinze G, Kikić Ž, Winkelmayer WC, Sunder-Plassmann G. Late Conversion of Kidney Transplant Recipients from Ciclosporin to Tacrolimus Improves Graft Function: Results from a Randomized Controlled Trial. PLoS One. 2015 Aug 13;10(8):e0135674. doi: 10.1371/journal.pone.0135674. eCollection 2015.
Riegersperger M, Plischke M, Steiner S, Seidinger D, Sengoelge G, Winkelmayer WC, Sunder-Plassmann G. Effect of conversion from ciclosporin to tacrolimus on endothelial progenitor cells in stable long-term kidney transplant recipients. Transplantation. 2013 Jun 15;95(11):1338-45. doi: 10.1097/TP.0b013e31828fabb3.